Products

The compound Montelukast Dicyclohexylamine Salt is a pharmaceutical substance used in the treatment of respiratory conditions such as asthma and allergic rhinitis. It is a salt derivative of Montelukast, a leukotriene receptor antagonist that works by blocking the action of leukotrienes, which are inflammatory substances produced in the body.This specific salt form, Montelukast Dicyclohexylamine Salt, is used to enhance the stability and solubility of the active compound, Montelukast. The addition of the dicyclohexylamine salt form improves the drug's pharmacokinetic properties, allowing for better absorption and distribution within the body. This, in turn, enhances the therapeutic effect of Montelukast and ensures an effective and consistent drug response.The dicyclohexylamine salt form of Montelukast also plays a crucial role in improving the drug's shelf life and preventing degradation. By forming a stable salt, it reduces the chances of chemical breakdown and increases the product's stability over time. This is especially important in pharmaceutical formulations, where the integrity of the active compound needs to be maintained for extended periods.Moreover, the choice of dicyclohexylamine as the salt-forming agent offers several additional benefits. Dicyclohexylamine is known for its low toxicity and high solubility, making it a suitable candidate for use in drug formulations. Its solubility properties ensure better dissolution and absorption of the Montelukast compound, enhancing its bioavailability and therapeutic efficacy.Overall, the Montelukast Dicyclohexylamine Salt serves as an important pharmaceutical formulation that optimizes the stability, solubility, and overall effectiveness of Montelukast. It enables the drug to be efficiently absorbed, distributed, and maintained over time, ultimately leading to improved patient outcomes in the treatment of respiratory conditions.